Koshinski Asset Management Inc. Has $5.19 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Koshinski Asset Management Inc. reduced its position in UnitedHealth Group Incorporated (NYSE:UNH) by 2.5% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 8,873 shares of the healthcare conglomerate’s stock after selling 227 shares during the period. Koshinski Asset Management Inc.’s holdings in UnitedHealth Group were worth $5,188,000 as of its most recent filing with the SEC.

Several other hedge funds have also bought and sold shares of UNH. Global Wealth Strategies & Associates lifted its position in UnitedHealth Group by 152.4% during the third quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate’s stock worth $31,000 after acquiring an additional 32 shares during the last quarter. Macroview Investment Management LLC raised its position in shares of UnitedHealth Group by 671.4% in the second quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate’s stock valued at $28,000 after buying an additional 47 shares in the last quarter. West Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the third quarter valued at approximately $32,000. Delos Wealth Advisors LLC raised its position in shares of UnitedHealth Group by 757.1% in the first quarter. Delos Wealth Advisors LLC now owns 60 shares of the healthcare conglomerate’s stock valued at $30,000 after buying an additional 53 shares in the last quarter. Finally, Bbjs Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $31,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Stock Performance

Shares of UNH stock traded up $0.35 during trading on Friday, reaching $598.05. 1,909,733 shares of the company’s stock traded hands, compared to its average volume of 2,855,968. The firm’s 50-day moving average is $583.64 and its 200 day moving average is $531.08. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $607.94. The company has a market capitalization of $552.25 billion, a P/E ratio of 39.66, a PEG ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The company had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same period in the previous year, the firm posted $6.14 EPS. The firm’s revenue was up 6.4% compared to the same quarter last year. Equities research analysts expect that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.40%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s payout ratio is 55.70%.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction dated Thursday, July 18th. The shares were sold at an average price of $579.03, for a total transaction of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now directly owns 29,501 shares in the company, valued at $16,812,029.88. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently issued reports on UNH shares. Morgan Stanley lifted their price objective on shares of UnitedHealth Group from $595.00 to $615.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Truist Financial lifted their price objective on shares of UnitedHealth Group from $600.00 to $640.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. TD Cowen lifted their price objective on shares of UnitedHealth Group from $546.00 to $601.00 and gave the company a “buy” rating in a research note on Wednesday, July 17th. Barclays lifted their price objective on shares of UnitedHealth Group from $560.00 to $604.00 and gave the company an “overweight” rating in a research note on Wednesday, July 17th. Finally, Royal Bank of Canada boosted their target price on shares of UnitedHealth Group from $555.00 to $615.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Two investment analysts have rated the stock with a hold rating, eighteen have issued a buy rating and two have given a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $617.37.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.